BE621398A - - Google Patents
Info
- Publication number
- BE621398A BE621398A BE621398DA BE621398A BE 621398 A BE621398 A BE 621398A BE 621398D A BE621398D A BE 621398DA BE 621398 A BE621398 A BE 621398A
- Authority
- BE
- Belgium
- Prior art keywords
- sugar
- viruses
- cores
- candy
- desc
- Prior art date
Links
- 235000009508 confectionery Nutrition 0.000 description 12
- 241000700605 Viruses Species 0.000 description 11
- 241000991587 Enterovirus C Species 0.000 description 9
- 208000000474 Poliomyelitis Diseases 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 6
- 229960005486 vaccine Drugs 0.000 description 6
- 230000002238 attenuated effect Effects 0.000 description 5
- 241000274177 Juniperus sabina Species 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000003926 Myelitis Diseases 0.000 description 1
- 101100125898 Neonectria sp. (strain DH2) iliE gene Proteins 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960001539 poliomyelitis vaccine Drugs 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 150000003355 serines Chemical class 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32661—Methods of inactivation or attenuation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE621398A true BE621398A (da) | 1900-01-01 |
Family
ID=194439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE621398D BE621398A (da) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE621398A (da) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0420785A3 (en) * | 1989-09-29 | 1991-07-31 | Nisshin Oil Mills Ltd | Stable immunogen composition |
| EP0603992A1 (en) * | 1992-12-22 | 1994-06-29 | University Of Cincinnati | Oral administration of immunologically active biomolecules and other therapeutic proteins |
-
0
- BE BE621398D patent/BE621398A/fr unknown
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0420785A3 (en) * | 1989-09-29 | 1991-07-31 | Nisshin Oil Mills Ltd | Stable immunogen composition |
| US5176909A (en) * | 1989-09-29 | 1993-01-05 | The Nisshin Oil Mills, Ltd. | Stable immunogen composition for oral administration |
| US5591433A (en) * | 1991-06-21 | 1997-01-07 | University Of Cincinnati | Oral administration of immunologically active biomolecules and other therapeutic proteins |
| EP0603992A1 (en) * | 1992-12-22 | 1994-06-29 | University Of Cincinnati | Oral administration of immunologically active biomolecules and other therapeutic proteins |
| EP0603992B1 (en) * | 1992-12-22 | 1996-10-09 | University Of Cincinnati | Oral administration of immunologically active biomolecules and other therapeutic proteins |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022256174B2 (en) | Microbiota restoration therapy (MRT) compositions and methods of manufacture | |
| Pardeshi et al. | Process development and quality attributes for the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanomedicine delivery: a state-of-the-art review | |
| US20230364159A1 (en) | Microbiota restoration therapy (mrt) compositions and methods of manufacture | |
| US12036250B2 (en) | Microbiota restoration therapy (MRT) compositions and methods of manufacture | |
| NO142866B (no) | Nye benzodiazepinderivater for anvendelse som ugangsmateriale og fremgangsmaate ved fremstilling derav | |
| WO2019241523A1 (en) | Microbiota restoration therapy (mrt) compositions and methods of manufacture | |
| BE621398A (da) | ||
| US10799539B2 (en) | Microbiota restoration therapy (MRT) compositions and methods of manufacture | |
| WO2023197484A1 (zh) | 马兜铃酸IVa在制备抗组胺或治疗肺炎药物中的应用 | |
| BE1005589A3 (fr) | Medicament pour le traitement de la dermatite. | |
| WO2002047725A2 (fr) | Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation | |
| FR2479690A1 (fr) | Medicament utile notamment pour le traitement de l'arthrite et son procede d'obtention par extraction des feuilles et rhizomes de polypodiaceae | |
| ES2314772T3 (es) | Composicion para la prevencion y tratamiento de afecciones catarrales. | |
| FR2836379A1 (fr) | Formes galeniques solides de medicaments homeopathiques, dont les allergenes ou antigenes, en dilutions homeopathiques pour preparation extemporanee pour un seul individu pour administration sublinguale | |
| WO2020143333A1 (zh) | 蒲公英甾酮在制备防治老年痴呆的药物中的应用 | |
| CN118697705B (zh) | 一种复方黄柏冻干粉及其制备工艺 | |
| CN111388494B (zh) | 落新妇苷在制备用于治疗胰腺炎的药物中的应用 | |
| CN115778985B (zh) | 僵蚕提取液的制备方法及应用 | |
| CN108042551A (zh) | 一种组合物在制备病毒性心肌炎治疗药物中的用途 | |
| CN118576718A (zh) | 一种鱼弹状病毒弱毒疫苗冻干保护剂、疫苗及其制备方法 | |
| HK40067062A (en) | Microbiota restoration therapy (mrt) compositions and methods of manufacture | |
| WO2004052384A1 (fr) | Proprietes antivirales, anti-infectieuses et cicatrisantes des extraits de dichrostachys glomerata | |
| HK1254281B (en) | Methods of manufacture of microbiota restoration therapy (mrt) compositions | |
| CN1742713A (zh) | 阿魏酸钠无菌原料药的制备方法 | |
| CN102716093A (zh) | 施普睿达冻干粉针剂及其制备方法 |